Evaluating the efficacy of head lift exercise(Shaker exercise) for dysphagia accompaning chemo-radiation therapy in head and neck cancer.

Evaluating the efficacy of head lift exercise(Shaker exercise) for dysphagia accompaning chemo-radiation therapy in head and neck cancer. - Evaluating the efficacy of head lift exercise(Shaker exercise) for dysphagia.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008836

Enrollment

Registered

2012-09-10

Start date

2012-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer

Interventions

Shaker exercise is underwent for swallowing exercise during chemo-radiation therapy. Mendelsohn exercise is underwent for swallowing exercise during chemo-radiation therapy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.histologically daiagnosed SCC 2.patients had untreatement head and neck squamous cell carcinoma who needs chemo-radio therapy. 3.Patient age 20 years and above, 89 years and below. 4. ECOG PS of 0, 1 or 2 and the patients who can attend a hospital as a outpatient. 5.Written informed consent. 6.Sufficient oral intake.

Exclusion criteria

Exclusion criteria: 1.Patients who has cervical spondylosis. 2.Patines who had been underzent operation for cervical spine. 3.Patiens who has severe cardiac, pulmonary, hepatic and renal disorders. 4.Pregnancy or lactating women or women with suspected pregnancy. 5. Lack of written informed consent. 6.Patients who had cerebral hemorrhage or subarachnoid hemorrhage within one month.

Design outcomes

Primary

Measure	Time frame
1.Analysis of anterior and superior movement of hyoid bone and larynx. 2. The maximum width of esophageal opening with videofluorography. 3.With or without misswallowing. 4.Pooling of saliva in pyriform sinus and epiglottic vallecura in fiber scopic imaging. 5.With or without tube feeding. 6.Quantity of oral intake. 7.Body waight and rate of body wight loss. 8.Transition of inflammatory response.	—

Secondary

Measure	Time frame
1.Duratation of hostpitalization and treatment. 2.Adverse event. 3.Rate of completion for treatment. 4.Survival rate.	—

Countries

Japan

Contacts

Public ContactJunkichi Yokoyam

Juntendo university school of medicine Department of Otolaryngology, head and neck surgery

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026